Study Models 60% Weight Regain Within One Year After Stopping GLP-1 Drugs
Researchers modeled weight regain after stopping GLP-1 receptor agonists, finding a plateau at 75% regained and emphasizing the need for long-term weight management.
- A University of Cambridge study found that people regained about 60% of the weight they lost within one year after stopping GLP-1 weight loss drugs.
- Researchers warned that if the regained weight is mostly fat rather than lean mass, individuals could be worse off than before using the drugs.
- The study showed that weight regain tends to plateau at around 75% of the original weight lost by 60 weeks, meaning about 25% of weight loss may be sustained long-term.
25 Articles
25 Articles
If you stop injecting, you usually increase quickly again. However, if the customer's follow-up is not completely lost, a new study shows.
You can help lose weight, but those who leave out preparations such as Ozempic, Wegovy and Mounjaro will quickly increase again. Only a quarter of the weight loss could possibly remain long-term.
Mapping the year-one weight trajectory after stopping GLP-1s
A year after stopping taking weight loss drugs such as Ozempic and Wegovy, people regain, on average, 60% of their lost weight – but beyond this, their weight regain plateaus, with individuals managing to keep off 25% of the weight lost to treatment, say researchers at the University of Cambridge.
Coverage Details
Bias Distribution
- 46% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium



















